Background-Arterial aneurysms exhibit a loss of elastin and an increase in the plasminogen activators urokinase plasminogen activator (u-PA) and tissue plasminogen activator (t-PA). Because u-PA, t-PA, and plasmin have a limited proteolytic activity against elastin, the role of plasminogen activators in the aneurysmal disease is unclear. To investigate this question, we overexpressed plasminogen activator inhibitor-1 (PAI-1), an inhibitor of t-PA and u-PA, in a rat model of aortic aneurysm. Methods and Results-Guinea pig-to-rat aortic xenografts were seeded with syngeneic Fischer 344 rat smooth muscle cells retrovirally transduced with the rat PAI-1 gene (LPSN group) or the vector alone (LXSN group). Some grafts were not seeded with cells (NO group). Western blots showed increased PAI-1 in grafts from the LPSN group compared with LXSN and NO groups. All grafts in the NO group (nϭ8) and 40% in the LXSN group ruptured between days 4 and 14. At 4 weeks in the LXSN group, the remaining unruptured grafts (nϭ6) were aneurysmal (diameter increase Ն100%), whereas in the LPSN group (nϭ6) none of the grafts had ruptured or were aneurysmal. Elastin was preserved in the LPSN group. t-PA, the major PA expressed in the model, was decreased in the LPSN group compared with the other groups, as determined by zymography. Quantitative zymography showed decreased levels of two matrix metalloproteinases (MMPs), a 28-kD caseinase, and activated MMP-9 in the LPSN group. Conclusions-The blockade of plasminogen activators prevents formation of aneurysms and arterial rupture by inhibiting MMP activation. (Circulation. 1998;98:249-255.)
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We developed a model of arterial aneurysm formation by taking advantage of the immunogenicity of guinea pig aortic extracellular matrix grafted into rats. 23, 24 During the rejection of the xenograft, monocyte/macrophages and T lymphocytes penetrate into the graft media where immunoglobulins are deposited. Elastin in the media is degraded, and the graft dilates and becomes an aneurysm by 1 month after engraftment. 24 When rat recipients are immunized with guinea pig aortic extracellular matrix before transplantation (preimmunization), the rate of rejection is increased and the xenograft ruptures. 25 During aneurysm formation and rupture in this model, the gelatinolytic and elastinolytic MMP-9 is upregulated. In this respect, this xenograft model reproduces the main features of the human disease (arterial dilation and rupture, elastin degradation, inflammatory cell infiltration in the media, and upregulation of MMPs). In a study using this model, we showed that the inhibition of MMPs by local overexpression of TIMP-1 blocks aneurysm formation and rupture and preserves elastin while blocking MMP-9 activity. 25 This result suggested to us that MMPs degrade arterial extracellular matrix and cause aneurysm formation and rupture in the xenograft model.
In the present study, we investigated PA activity during aneurysm formation in the xenograft model. To block PA activity, we overexpressed PAI-1 by seeding syngeneic rat SMCs retrovirally transduced with rat PAI-1 cDNA. We studied the impact of PAI-1 overexpression on MMP activity and aneurysm formation and rupture.
Methods

Animal Model
Male Fischer 344 rats (250 and 80 g) and male Hartley guinea pigs (400 g) from Simonsen Laboratories Inc (Gilroy, Calif) were housed and cared for in the Animal Facility of the University of Washington School of Medicine, Seattle. All animal experimentation complied with the National Institutes of Heath guidelines (NIH publication 86-23). All protocols were approved by the Animal Care Committee of the University Washington School of Medicine.
Orthotopic engraftments of 10-mm-long segments of decellularized guinea pig aorta (xenograft) or Fischer 344 rat aorta (isograft) into Fischer 344 rats were performed as previously described. 23 For decellularization, the grafts were incubated in 0.1% SDS to obtain arterial extracellular matrix without cells. 24 The xenografts dilate and exhibit a progressive loss of elastin, whereas the rat isografts do not dilate after implantation and elastin in their media is preserved. Therefore, we compared decellularized xenografts and isografts to investigate PA and PAI activities during aneurysm formation. To increase the rejection process and obtain xenograft rupture, 80-g Fischer 344 rats were immunized by repeated injections of homogenized decellularized guinea pig arterial extracellular matrix with no adjuvant before transplantation (preimmunization). Preimmunized rats were used as recipients for all graft cell seeding experiments.
Graft diameter and length were measured after engraftment and at harvest. A diameter increase of Ͼ100% was defined as graft aneurysm degeneration. This definition corresponds to the generally accepted clinical criterion for significant aortic aneurysm dilation.
Seeding of PAI-1-Transduced Cells
The preparation of replication-deficient retrovirus and the isolation and transfection of the Fischer 344 rat SMCs has been described elsewhere. 26 The rat PAI-1 gene (a generous gift from Dr Thomas Gelehrter 27 ) was slightly modified by the addition of a perfect Kozak sequence at the 5Ј end and then cloned into the multiple cloning site of the retroviral vector LXSN. The LXSN vector and packaging cell lines were a generous gift from Dr A.D. Miller, Fred Hutchinson Cancer Research Center, Seattle, Wash. 28 Transduced cells were seeded into the graft lumen just after transplantation through a PE 10 catheter introduced through a transverse arteriotomy. Cells (8ϫ10 6 ) suspended in 5% BSA were used for each graft. The aortotomy was closed with a 10/0 Ethicon suture, and flow was reestablished.
Elastin Assay
Desmosine, a cross-linking amino acid present only in elastin, was quantified as a measure of elastin content in the tissue. The samples (5 mm long) were freeze-dried, weighed, and hydrolyzed in 6N HCl at 105°C for 24 hours. The samples were evaporated to dryness and redissolved in 500 L of distilled water, and the radioimmunoassay for desmosine was performed in triplicate on 5-L samples as described previously.
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Western Blots
For Western analysis, pools of 3 grafts in each group were cut with razor blades, crushed in a mortar, and extracted in iced buffer containing 75 mmol/L potassium acetate, 0.3 mol/L NaCl, 0.1 mol/L L-arginine, and 10 mmol/L EDTA in 0.25% Triton X-100, pH 4.2, for 15 minutes 30 and centrifuged at 10 000 rpm for 10 minutes at 4°C. Protein content in the supernatant was measured against a BSA standard. Samples (20 g) were subjected to 10% SDS-PAGE and transferred onto a nylon membrane (Bio-Rad). Membranes were blocked with 3% BSA and incubated with either a rabbit anti-rat PAI-1 antibody (1 g/mL) (American Diagnostica Inc), goat antihuman t-PA antibody (15 g/mL) (American Diagnostica Inc), or sheep anti-human MMP-3 serum (dilution 1:1000, a gift from Dr H. Nagase, University of Kansas Medical Center, Kansas City, Kan). Secondary antibodies were anti-rabbit or anti-sheep IgG conjugated with alkaline phosphatase (dilution, 1/7500) with nitro blue tetrazolium and BCIP as a substrate (Promega). Controls included incubation with a sheep or goat serum. In addition, Western blots of the same extracts incubated with an anti-u-PA antibody (American Diagnostica Inc) did not show bands at the same molecular weight level as Western blots with anti-PAI-1 and anti-MMP-3 antibodies.
Zymography for PAs and Reverse Zymography for PAIs
Pools of 3 grafts were extracted as described for Western blots. Equal protein amounts in each group were subjected to 10% SDS-PAGE. The gel was rinsed in 2.5% Triton X-100 and incubated in 1ϫPBS for 20 minutes each. The gel was applied to an agar gel containing milk casein and human glu-type plasminogen (American Diagnostica Inc) in 1% agarose. 31 After incubation at 37°C in a moist chamber, gels were photographed with dark-field illumination. Areas of casein lysis appeared as dark areas in a white background. t-PA and u-PA were identified by incorporating selective inhibitors into the gel (anti-human t-PA No. 387 from American Diagnostica Inc and 1 mmol/L amiloride from Sigma Chemical Co, respectively). 31 For reverse zymography to detect PAIs, the preparation of the underlay was the same as for zymography, except that 250 mU/mL u-PA was added to the underlay. Areas of PAI activity appeared as white on a black background.
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Gelatin and Casein Zymography of MMPs
Pools of 3 grafts were extracted with 0.05 mol/L Tris, pH 7.5, containing 0.01 mol/L CaCl 2 , 2 mol/L guanidine, and 0.2% Triton X-100. Extracts were dialyzed against 0.05 mol/L Tris/0.2% Triton X-100, pH 7.5, for 48 hours at 4°C. Equal amounts of extracted proteins were subjected to 10% SDS-PAGE in gels containing 0.1% gelatin or 0.1% casein. Gels were then incubated in 2.5% Triton X-100 for 30 minutes, further incubated for 18 hours at 37°C in 50 mmol/L Tris/10 mmol/L CaCl 2 , pH 8.2, and finally stained with 0.008% Coomassie blue R (Sigma). 32 Various proteinase inhibitors (30 mmol/L EDTA [Sigma]), recombinant TIMP-1 (a gift from Dr H. Nagase), or 1 mmol/L PMSF (Sigma) was added to the incubating buffer to assess the class of proteinase. Activation with 1 mmol/L APMA was used to identify MMP activities. 33 On treatment of extracts with 1 mmol/L APMA, there was a shift of the highmolecular-weight gelatinolytic bands of MMP-9 to a lowermolecular-weight (80-kD) band, suggesting that the latter is activated MMP-9 (data not shown). For quantification, gels containing the extracts from the groups of grafts to be compared were scanned with ScanJet 3C/T, Hewlett Packard, using Adobe Photoshop 3.0. MMP-9 -related gelatinolytic bands (100, 90, and 80 kD) and MMP-3-related caseinolytic bands (48 and 28 kD) were quantified with Image Quant (v3.3, Molecular Dynamics). For MMP-9, results were plotted against a standard curve generated on the same gel with purified human MMP-9 (a gift from Dr H. Welgus, Washington University, St Louis, Mo). 
Statistical Analysis
Results t-PA Activity and Graft Degeneration
Xenografts become aneurysmal by 4 weeks after implantation. 24, 25 To establish a relationship between aneurysm formation and PA activity in the xenograft model, we extracted pools of decellularized isografts and xenografts harvested 1 and 2 weeks after implantation. Inflammatory cell penetration into the media is evident at these times in xenografts but not isografts. 24 By zymography, graft extracts exhibited a plasminogendependent, caseinolytic 72-kD band that was more intense in xenograft than in isograft extracts (Figure 1 ). This caseinolytic band was inhibited by a blocking anti-t-PA antibody but not by amiloride. A 55-kD activity appeared after a longer time of incubation (Ͼ48 hours) and was inhibited by amiloride, not by the anti-t-PA blocking antibody, which demonstrated that it was u-PA. Western blots with anti-t-PA antibody showed a 72-kD band more intense in xenografts than in isografts 1 and 2 weeks after engraftment in naive rats (data not shown). No immunoreactive u-PA could be detected on Western blots. On reverse zymography, a 50-kD band was visible in graft extracts. This band, which corresponds to the molecular weight of PAI-1, was intense in isografts and low or absent in xenografts (Figure 1) .
Xenografts implanted in preimmunized animals showed similar patterns of PA activity at day 3, but no PAI-1 activity could be detected on reverse zymograms (data not shown).
Graft Diameter and Rupture in Preimmunized Rats
All nonseeded grafts placed in preimmunized rats ruptured between 4 and 14 days. Four of 10 LXSN cell-seeded grafts (40%) ruptured within 4 weeks. The remaining 6 grafts were aneurysmal at 4 weeks (Figure 2) . None of the 6 LPSN cell-seeded grafts ruptured, and none were aneurysmal at 4 weeks.
Elastin Network and Desmosine Content in Preimmunized Rats
Histological cross sections of xenografts harvested 4 weeks after implantation show that elastin was completely deleted in the LXSN cell-seeded group, whereas the internal elastic lamina and the lamellae in the media were preserved in the LPSN cell-seeded grafts (Figure 3) . Desmosine content at 4 weeks was lower in the LXSN cell-than in the LPSN cell-seeded grafts ( Figure 4 ). Taken together, these results indicate that elastin structure and content were preserved in the LPSN cell-seeded grafts but not the LXSN cell-seeded grafts. Cell nuclear staining showed similar amounts of inflammatory cells in the media of LXSN cell-and LPSN cell-seeded grafts.
PAI-1 Protein Overexpression in Preimmunized Rats
Extracts of LXSN cell-and LPSN cell-seeded grafts at 3 days after implantation in preimmunized rats showed equal amounts of the 50-kD band corresponding to rat PAI-1 on Western blots. On reverse zymograms, PAI-1 activity could not be detected in nonseeded, LXSN cell-seeded, or LPSN cell-seeded grafts implanted in preimmunized rats (data not shown). However, bands between 104 and 160 kD were more abundant in the LPSN cell-seeded than in the LXSN cellseeded grafts ( Figure 5 ); these bands might be complexes formed between PAI-1 and PAs or vitronectin 34 in the LPSN cell-seeded grafts. Western blots performed under reducing conditions (2 mmol/L DDT) showed, in addition to the 50-kD band, sharp 29-and 27-kD bands in the LPSN cell-seeded but not in the LXSN cell-seeded grafts, which might correspond to partially degraded forms of PAI-1. 
PA Activity in the Seeded Grafts at Day 3 in Preimmunized Rats
PA activities were analyzed after a 3-day implantation in preimmunized rats. At this early time point, no graft had ruptured, and therefore comparisons between groups could be made. The major PA activity was a 72-kD band inhibited by anti-t-PA antibody and not by amiloride, which hence was t-PA. In the LPSN cell-seeded grafts, the t-PA activity was much reduced compared with LXSN cell-seeded grafts and nonseeded grafts ( Figure 6 ).
MMP Activity in the Seeded Grafts at Day 3 in Preimmunized Rats
On gelatin zymograms, extracts from grafts implanted for 3 days in preimmunized rats displayed bands of gelatinolysis between 100 and 80 kD and between 72 and 68 kD. These bands were inhibited by 30 mmol/L EDTA and by TIMP-1 but not by 1 mmol/L PMSF and therefore were MMP activities likely to correspond to MMP-9 (M r 100 to 80 kD) and MMP-2 (M r 72 to 68 kD) ( Figure 7A ). In LXSN cell-seeded grafts, bands were shifted toward lower molecular weights (M r 90 and 80 kD), whereas in LPSN cell-seeded grafts, bands were at the highest molecular weights (100 and 90 kD) ( Figure 7B ), suggesting a lesser degree of MMP-9 activation in the LPSN cell-seeded grafts. No difference in MMP-2 zymographic pattern was evident between the 2 groups.
A 28-kD lytic band appeared on casein zymograms and was more intense in the LXSN cell-than in the LPSN cell-seeded grafts ( Figure 8A and 8B ). This lytic activity was inhibited by 30 mmol/L EDTA and by 2 g/mL TIMP-1 in the incubating buffer but not by 1 mmol/L PMSF and therefore is an MMP activity. The 28-kD band was not detected on Western blots with an anti-human MMP-3 antibody. However, a 55-kD band corresponding to proMMP-3 was present by Western analysis in the LPSN cell-but not in the LXSN cell-seeded grafts (data not shown). Furthermore, the fact that the 28-kD band was unaffected by incubation with 1 mmol/L APMA 33 ruled out the possibility that this 28-kD band could be MMP-7 (matrilysin). These results suggest that LPSN cell seeding prevented the conversion of proMMP-3 into its activated 28-kD form.
Discussion
The serine proteases t-PA, u-PA, and plasmin compose a system involved in fibrinolysis and in focal degradation of fibrin and extracellular matrix during angiogenesis, cancer metastasis, and arthritis. 35, 36 In arteries mechanically injured in vivo, t-PA is upregulated during SMC migration from the media to the intima, a process in the arterial response to injury. 31 Treatment with heparin, which decreases smooth muscle migration after arterial injury, inhibits the expression of t-PA. 37 In arterial explants, the migration of SMCs is inhibited by an anti-t-PA antibody. 38 These results suggest that the lysis of arterial extracellular matrix could involve t-PA. In atherosclerotic plaques and arterial aneurysms, inflammation is thought to be associated with extracellular matrix lysis leading to thrombosis and arterial enlargement and either fibrous cap or arterial wall rupture. [39] [40] [41] [42] Plasmin, u-PA, and t-PA have been detected in these arterial lesions, 43, 44 as well as PAI-1. 45 In a model in mice, u-PA appears to be necessary for aneurysm formation. 46 Because plasminogen is synthesized in the liver, its activation to plasmin in focal areas of the arterial wall is thought to be mediated by PAs secreted by SMCs, endothelial cells, and inflammatory cells. In particular, mononuclear phagocytes have been shown to infiltrate the adventitia and the media of arterial aneurysms. 4, 5 In this report, we show in a xenograft model of arterial aneurysm formation that t-PA activity is upregulated. We show that PAI-1 overex- To identify t-PA and u-PA activity, gels were treated with a blocking antibody to t-PA or amiloride, respectively. pression preserves elastin in the media while decreasing t-PA activity, preserving elastin in the media, and preventing aneurysm formation. A similar approach using PAI-2 overexpression in vivo has been shown to inhibit metastasis, a phenomenon in which extracellular matrix lysis is necessary for the movement of transformed cells in tissues. 47 PAIs form inhibitory complexes with their C-terminus end and the catalytic domain of PAs. 48, 49 In addition, inactive t-PA-PAI-1 complexes compete with active t-PA to occupy binding sites on fibrin. 50 By these two mechanisms, the balance between PAs and PAIs might modulate PA activity in tissues. PAI-1 is secreted by endothelial cells, 51 SMCs, and macrophages. 52 PAI-1 content in atherosclerotic and aneurysmal arteries might be increased by the influx of platelets and mononuclear phagocytes. 52 However, despite its presence in inflammatory arterial lesions, the concentration of PAI-1 might be inadequate for full PA blockade. In addition, PAI-1 could be inactivated by oxidants generated by inflammatory cells and by thrombin. 49, 53 Our results comparing xenografts with isografts shows that the degradation of medial elastin is accompanied by an upregulation of t-PA activity and a parallel decrease in PAI-1 activity in graft extracts.
Plasmin degrades extracellular matrix glycoproteins, 54 fibronectin, laminin, and vitronectin, 35 but the PA/plasmin system has no direct proteolytic activity against elastin and collagens. 55 These matrix proteins are substrates for MMPs, such as MMP-9, MMP-2, and MMP-12. [56] [57] [58] [59] [60] [61] We recently showed in the xenograft model that the inhibition of MMPs by overexpression of an inhibitor of MMPs, TIMP-1, also results in elastin preservation and prevents aneurysm formation and rupture. 25 These findings underline the importance of MMPs in arterial extracellular matrix degradation. Because most MMPs are secreted as zymogens, 62 MMP activity in the extracellular space is dependent on the activation of the zymogen. In vitro studies suggest that the PA/plasmin system might be a major pathway of MMP activation. 21, 22 In particular, plasmin can convert proMMP-3 (stromelysin 1) into active MMP-3. 18 Therefore, the PA/plasmin system could trigger extracellular matrix degradation by activating the MMP pathway of proteolysis. ProMMP-3 has an apparent molecular weight of 57 kD and can be cleaved into lowermolecular-weight fragments (45, 28, and 24 kD) that have similar proteolytic activities for proteoglycans, type I gelatin, type IV collagen, fibronectin, and laminin.
63,64 PAI-1 overexpression resulted in a decrease in 28-kD caseinolytic activity. These activities can be inhibited by EDTA and TIMP-1 and are likely to be activated forms of MMP-3. Moreover, Western blot analysis showed a band of 54-kD proMMP-3 in grafts seeded with LPSN cells but not with LXSN cells. Taken together, these results suggest that PAI-1 overexpression partially prevented MMP-3 activation and resulted in a decrease in MMP-3 active forms. Therefore, the PA/plasmin system could trigger extracellular matrix degradation by activating the MMP pathway of proteolysis.
The MMP-9 pattern of activation was also modified by PAI-1 overexpression. Higher-molecular-weight gelatinolytic activities were detected in the LPSN cell-seeded grafts compared with LXSN cell-seeded grafts. u-PA and plasmin have been shown to activate MMP-9.
21,22 PAI-1 overexpression in xenografts might also lower MMP-9 activation by lowering MMP-3, because MMP-3 can activate MMP-9. 65 Because MMP-9 has elastinolytic properties as well as gelatinolytic activities, 58 a decrease in MMP-9 activation might account in part for limited elastinolysis on PAI-1 overexpression in xenografts ( Figure 9 ).
Our data show for the first time that the blocking of t-PA activity by PAI-1 overexpression results in the prevention of aneurysm degeneration and rupture. These results together with results from TIMP-1 overexpression experiments 25 strongly support the idea that MMPs are a major pathway of elastin degradation in the xenograft model of aneurysm. Pharmacological strategies to block aneurysm formation and rupture might include the direct blocking of MMPs as well as the prevention of MMP activation by blocking the PA/plasmin system. 
